Clarivate Plc CLVT

NYS: CLVT | ISIN: JE00BJJN4441   17:00
6,350 USD (+1,60%)
(+1,60%)   17:00

9 mei 2024 · OMRON Selects IPfolio from Clarivate · Persbericht

8 mei 2024 · Clarivate Reports First Quarter 2024 Results · Persbericht

7 mei 2024 · Clarivate Introduces Epidemiology Intelligence™ for Precision Patient Population Analysis · Persbericht

2 mei 2024 · Clarivate Enhances Cortellis CMC Intelligence with Post-Approval Module to Accelerate Regulatory Success · Persbericht

1 mei 2024 · Clarivate Declares Dividend on Mandatory Convertible Preferred Shares · Persbericht

30 april 2024 · BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report · Persbericht

24 april 2024 · Clarivate joins United Nations SDG Publishers Compact · Persbericht

23 april 2024 · Clarivate Acquires Global QMS, Inc., Expanding Life Sciences & Healthcare Segment into New Markets · Persbericht

17 april 2024 · Clarivate Launches LatAm Market Tracking Solution in Partnership with Global Healthcare Intelligence Enabling Real-Time Tracking of Medical Device Markets · Persbericht

15 april 2024 · Clarivate to Report First Quarter 2024 Results on May 8, 2024 · Persbericht

1 april 2024 · Clarivate Leadership Presents at Recent Investor Conferences · Persbericht

21 maart 2024 · Clarivate Acquires AI Start Up to Accelerate Strategy and Business Development Success for Life Sciences & Healthcare Clients · Persbericht

20 maart 2024 · New Webinar: Clarivate in the Age of AI - Driving Innovation in Intellectual Property Management and Decision Making · Persbericht

13 maart 2024 · New Webinar: Clarivate in the Age of AI - Empowering Our Life Sciences & Healthcare Customers to Create a Healthier Tomorrow · Persbericht

7 maart 2024 · Clarivate to Present at the BofA Securities 2024 Information & Business Services Conference on March 14 · Persbericht

6 maart 2024 · New Webinar: Clarivate in the Age of AI - Innovation Rooted in Academia · Persbericht

5 maart 2024 · Clarivate Reveals Top 100 Global Innovators 2024 · Persbericht

4 maart 2024 · Clarivate and Exor Sign Agreement Under Which Suzanne Heywood Will Be Nominated to Stand for Election to the Company's Board of Directors · Persbericht

27 februari 2024 · Clarivate Reports Fourth Quarter and Full Year 2023 Results · Persbericht

23 februari 2024 · Clarivate Recognized in the WTR 1000 2024 for Trademark Business · Persbericht

Mijn selecties